The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome

To gain further knowledge on the preclinical phase of Alzheimer’s disease (AD), we sought to characterize cognitive performance, neuroimaging and plasma-based AD biomarkers in a cohort of non-demented adults with down syndrome (DS). The goal of the down syndrome biomarker Initiative (DSBI) pilot is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafii, Michael S., Wishnek, Hannah, Brewer, James B., Donohue, Michael C., Ness, Seth, Mobley, William C., Aisen, Paul S., Rissman, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568340/
https://www.ncbi.nlm.nih.gov/pubmed/26441570
http://dx.doi.org/10.3389/fnbeh.2015.00239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568340/
https://www.ncbi.nlm.nih.gov/pubmed/26441570
http://dx.doi.org/10.3389/fnbeh.2015.00239

Ejemplares similares